Free Trial

Nephros (NEPH) SEC Filings & 10K Form

Nephros logo
$1.54 +0.02 (+1.32%)
(As of 12/20/2024 05:16 PM ET)

Recent Nephros SEC Filings

DateFilerForm TypeView
11/14/2024
3:03 PM
Nephros (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/13/2024
3:15 PM
Nephros (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/17/2024
4:18 PM
Nephros (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
05/30/2024
3:35 PM
Amron Arthur H (Reporting)
Nephros (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/24/2024
3:05 PM
Nephros (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/23/2024
11:15 PM
Nephros (Filer)
Form EFFECT
05/16/2024
3:29 PM
Amron Arthur H (Reporting)
Nephros (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/01/2024
7:00 AM
Nephros (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/12/2024
3:10 PM
Nephros (Filer)
Form ARS
04/12/2024
3:10 PM
Nephros (Filer)
Form ARS
03/14/2024
3:43 PM
DAVIDSON CHARLES E (Reporting)
JACOBS JOSEPH (Reporting)
Nephros (Issuer)
WEXFORD CAPITAL LP (Reporting)
Wexford GP LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:NEPH) was last updated on 12/21/2024 by MarketBeat.com Staff
From Our Partners